Modification of seed fatty acid composition by crispr/cas9targetting the fatty acid elongase1 in camelina sativa
Başlık çevirisi mevcut değil.
- Tez No: 708054
- Danışmanlar: Belirtilmemiş.
- Tez Türü: Yüksek Lisans
- Konular: Ziraat, Agriculture
- Anahtar Kelimeler: Belirtilmemiş.
- Yıl: 2018
- Dil: İngilizce
- Üniversite: Unıversıty Of Montana
- Enstitü: Yurtdışı Enstitü
- Ana Bilim Dalı: Belirtilmemiş.
- Bilim Dalı: Belirtilmemiş.
- Sayfa Sayısı: Belirtilmemiş.
Özet
Özet yok.
Özet (Çeviri)
The low-input oilseed crop Camelina (Camelina sativa (L.) Crantz) is known for its high omega-3 (18:3) content, short growth season, and facile gene transformation. Camelina mostly contains unsaturated fatty acids, however its fatty acid composition needs optimization depending on the end uses, for example reduction of unsaturated fatty acid to use as biodiesels, or enhancing omega-3 fatty acid content to use as nutritional supplements. Very long chain fatty acid (VLCFAs, C20-C24), are undesirable for human consumption, and their accumulation in seed oil also needs to be diminished. VLCFAs are produced by the catalytic action of fatty acid elongase1 (FAE1), and Camelina contains three alleles of FAE1 genes (FAE1-A, FAE1-B, and FAE1-C) due to its allohexaploid nature. Recently, VLCFAs in camelina were decreased along with polyunsaturated fatty acids (PUFAs) using the RNA interference (RNAi) technology. A low VLCFA line was also isolated from ethyl methanesulfonate (EMS) induced mutants. Sequencing results indicated that FAE1-B gene was mutated and resulted in 60% reduction in VLCFAs, but other two FAE1 copies were presumably still active in the mutant. To address this multipleallele-knockout-at-once problem, here I investigated the effect of knocking out three alleles of FAE1 genes using CRISPR technology with egg cell-specific Cas9 expression. Due to the germline mutation, homozygous FAE1 knockout mutants were successfully created in a single generation. VLCFA accumulation was significantly decreased from 22% of total fatty acids in wild type to less than 2% in transgenic plants, and the C18 unsaturated fatty acids were improved since 18:1 substrates were diverted to desaturation pathway, rather than elongation. Analysis of the fatty acid composition of four transgenic generations indicated that the mutations that cause low VLCFA genotype were heritable. There was no significant difference observed in seed weight, plant height, total oil content, and seed germination in Cas9-induced mutants compared to the wild type. This study showed that polyploid Camelina can be modified rapidly and effectively through CRISPR/Cas9 to achieve desired fatty acid composition.
Benzer Tezler
- Development and evaluation of a super critical fluid fractionation system: Preliminary studies on fatty acid methyl esters of tomato seed oil
Kritiküstü akışkan ayrıştırma sisteminin geliştirilmesi ve değerlendirilmesi: Domates çekirdeği yağı yağ asidi metil esterleri üzerine yapılan ön çalışmalar
HATİCE AHUNBAY
Yüksek Lisans
İngilizce
1996
Kimya MühendisliğiBoğaziçi ÜniversitesiPROF.DR. ÖNER HORTAÇSU
Y.DOÇ.DR. MURAT DERVİŞOĞLU
- Türkiye kökenli aspir tohum yağlarının transesterifikasyonu ve dizel yakıt alternatifi olarak değerlendirilmesi
Transesterification of safflower seed oil of Turkish origin and its evaluation as a diesel fuel alternative
ASLI IŞIĞIGÜR
- Çoklu amaçların çözümlemesinde amaç programlaması ile genelleştirilmiş ters yaklaşımı ve yem sanayiinde bir uygulama
Goal programming and generalieed inverse approaches in the multi-objective analysis and application in feed industry
HASAN BAL
- Mus musculus türü farelerde gözün gelişimi
The Development of eve of the albino mus musculus species of mice
EMEL YOLAL
Yüksek Lisans
Türkçe
1984
MorfolojiCumhuriyet ÜniversitesiMorfoloji (histoloji ve Embriyoloji) Ana Bilim Dalı
DOÇ. DR. ERDOĞAN GÜRSOY
- Plazma arkı eldesi ve yüzey bölgesi modifikasyonunda kullanılabilirliği
Başlık çevirisi yok
ÖZKAN ÖZİPEKLİLER
Yüksek Lisans
Türkçe
1986
Makine MühendisliğiUludağ ÜniversitesiMakine Mühendisliği Ana Bilim Dalı
DOÇ. DR. HALİM DEMİRCİ